Andere talen Sol-Gel Technologies Ltd.

Aandelen

SLGL

IL0011417206

Beurs gesloten - Nasdaq Andere beurzen 22:30:01 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,782 ^USD	+9,75%		-15,00%	-29,23%

13/03	Sol-Gel Technologies Ltd. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
29/02	Sol-Gel Technologies Ltd. Kiest Yuval Yanai als Externe Bestuurder	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream	01/04
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments	13/03
Sol-Gel Technologies Ltd. Elects Yuval Yanai as External Director	29/02
Sol-Gel Technologies Ltd. Screens First Patient for SGT-610 Phase 3 Study	30/11
Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study	30/11
Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610	28/11
Sol Gel Technologies : INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K - Form 6-K	20/11
Sol-Gel Technologies Ltd. Announces Resignation of Shmuel Ben Zvi from Board	20/11
Sol-Gel Technologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update	09/11
Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference	30-08-23
Sol-Gel Technologies Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10-08-23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update	10-08-23
Sol-Gel Technologies Ltd. Appoints Sharon Kochan to the Board of Directors	27-07-23
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	21-06-23
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	14-06-23
Sol-Gel Technologies, Searchlight Pharma Sign Licensing Deals for 2 Dermatology Drugs	06-06-23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada	06-06-23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO and EPSOLAY in Canada	06-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sol-Gel Technologies Ltd.

Aandelen

SLGL

IL0011417206

Andere talen

Filters